Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Bos, M.M.E.M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(13)
+
-
Availability
Open access
(2)
+
-
Metadata Only
(12)
+
-
Creation Date
2013
(6)
+
-
2015
(3)
+
-
2012
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(13)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(13)
+
-
Topic
Cancer
(2)
+
-
chemotherapy
(2)
+
-
Author
Bos, M.M.E.M.
(14)
+
-
Kroep, J.R.
(6)
+
-
Jonge, E. de
(5)
+
-
Portielje, J.E.A.
(5)
+
-
Linn, S.C.
(4)
+
-
Bosch, J. van den
(3)
+
-
E. boven
(3)
+
-
Groot, S.M. de
(3)
+
-
Honkoop, A.H.
(3)
+
-
Jager, A.
(3)
+
-
Keizer, N.F. de
(3)
+
-
Lam, S.W.
(3)
+
-
Nortier, J.W.R.
(3)
+
-
Tinteren, H. van
(3)
+
-
Bakhshi-Raiez, F.
(2)
+
-
Braun, J.J.
(2)
+
-
Charehbili, A.
(2)
+
-
Dumay, I.
(2)
+
-
Foekens, J.A.
(2)
+
-
Gratama, J.W.
(2)
+
-
Guchelaar, H.J.
(2)
+
-
Heijns, J.B.
(2)
+
-
Kessels, L.
(2)
+
-
Kraan, J.
(2)
+
-
M. los
(2)
+
-
Martens, J.W.M.
(2)
+
-
Mostert, B.
(2)
+
-
Onstenk, W.
(2)
+
-
Sieuwerts, A.M.
(2)
+
-
Sleijfer, S.
(2)
+
-
Smit, V.T.H.B.M.
(2)
+
-
Smorenburg, C.H.
(2)
+
-
Velde, C.J.H. van de
(2)
+
-
Velden, A.M.T. van der
(2)
+
-
Show more
Language
en
(14)
+
-
Search results
(1 - 14 of 14)
show grid
show list
save search
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer: Current Practices and Patients' Perceptions of Uncertainty
Intensive care admission of cancer patients: a comparative analysis
Genetic polymorphisms (SNPs) as predictive markers for paclitaxel-induced peripheral neuropathy (PNP) and capecitabine-induced hand-foot syndrome (HFS) in HER-2 negative metastatic breast cancer patients
Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial
Bloodstream infections in patients with or without cancer in a large community hospital
Outcomes of intensive care unit admissions after elective cancer surgery
Characteristics of critically ill cancer patients in the Netherlands
Plasma VEGF-a, angiopoietin-2 (ANG2) and soluble(s)TIE2 in patients (pts) with HER2-negative locally recurrent or metastatic breast cancer (LR/MBC) treated with first-line bevacizumab (A) and paclitaxel (T) without or with capecitabine (X)
A combined EpCAM and MCAM circulating tumor cell (CTC) CellSearch enrichment to improve CTC capture rate in stage II/III breast cancer: A Dutch Breast Cancer Trialists' Group (BOOG) side study
Safety and efficacy of the addition of simvastatin to panitumumab in KRAS mutant metastatic colorectal cancer patients
Outcomes of cancer patients after unplanned admission to general intensive care units
Low complication rates in the use of port-a-caths in oncology patients